Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Strive acquisition of Semler Scientific
We are advising Strive on the acquisition
Heineken $3.2 billion acquisition of FIFCO beverage and retail businesses
We are advising Heineken on the transaction
British American Tobacco $750 million notes offering
The investment-grade notes are due 2033
Grayscale CoinDesk Crypto 5 ETF approved as first U.S. multi-asset crypto ETF
We advised Grayscale on securing SEC approval for the NYSE Arca listing
Applied Materials $1 billion senior notes offering
The investment-grade notes are due 2031 and 2036
GenFleet Therapeutics HK$1.82 billion IPO
We advised GenFleet on its IPO and HKEX listing
Oscar Health $410 million convertible senior subordinated notes and capped call transactions
The 2.25% convertible notes are due 2030
Norwegian Cruise Line Holdings comprehensive refinancing transactions
The transactions included new debt, exchangeable debt, registered direct equity offerings and concurrent tender offers
Bombardier $250 million senior notes offering
The investment-grade senior notes are due 2033
Natura sale of Avon International to Regent
We are advising Natura on the sale